secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2026-10-16T21:00:14+00:00
Accession:  0001193125-26-424228
Event type: debt
Sentiment:  neutral
Materiality: 0.30
Item codes: 2.03, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

TuHURA Biosciences draws $650K under $50M Parkview revolving credit facility
----------------------------------------------------------------------------

- On October 9, 2026 the Company borrowed an additional $650,000 under the revolving credit facility; proceeds to be used for general corporate purposes.
- Facility is with Parkview Holdings One LLC under a Loan Agreement dated April 21, 2026, matures April 21, 2031, maximum availability $50 million.
- Company notes the lender is an affiliate of its largest stockholder and cites potential conflicts of interest as a risk factor.
- Filing warns funds available under the Loan Agreement may be insufficient to fund operations and development programs as anticipated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526424228/0001193125-26-424228-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526424228/hura-20261009.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-424228

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer